LC106: Clinical Trials

2 trials of LC106, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 2

Follow LC106: new trials by email Literature Review of LC106 trials Research Report on LC106

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Clinician-administered Vaginal Live Biotherapeutic Product
LC106 - Bacterial Vaginosis
Early Phase 1CompletedCaroline Mitchell262026-04-282026-09-29
Vaginal lIve Biotherapeutic RANdomized Trial
LC106, LC115, Placebo - Bacterial Vaginosis
Early Phase 1CompletedMassachusetts General Hospital242024-02-012025-03-25

Conditions studied

Vaginosis, Bacterial (2)  ·  Vaginitis (1)

Sponsors

Caroline Mitchell (1)  ·  Massachusetts General Hospital (1)

Countries

South Africa (2)  ·  United States (2)

Top investigators

Caroline M Mitchell, MD, MPH (1)  ·  Caroline Mitchell, MD, MPH (1)  ·  Disebo Potloane, MD (1)

Results publications

PMID 41050878, PMID 41382078